Martin C. Michel
Department of Pharmacology and Pharmacotherapy and Department of Urology
Academic Medical Center
University of Amsterdam
Netherlands
Name/email consistency: high
- Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study. Michel, M.C., Wetterauer, U., Vogel, M., de la Rosette, J.J. Drug. Saf (2008)
- Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Michel, M.C., Barendrecht, M.M. Pharmacol. Ther. (2008)
- Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Michel, M.C., Oelke, M., Goepel, M., Beck, E., Burkart, M. Neurourol. Urodyn. (2007)
- Vascular effects of sphingolipids. Michel, M.C., Mulders, A.C., Jongsma, M., Alewijnse, A.E., Peters, S.L. Acta. Paediatr. Suppl (2007)
- Ligand-directed signaling: 50 ways to find a lover. Michel, M.C., Alewijnse, A.E. Mol. Pharmacol. (2007)
- Tolerability of amine uptake inhibitors in urologic diseases. Michel, M.C., Ruhe, H.G., de Groot, A.A., Castro, R., Oelke, M. Curr. Drug. Saf (2006)
- Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL). Michel, M.C., Chapple, C.R. Eur. Urol. (2006)
- Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Michel, M.C., Vrydag, W. Br. J. Pharmacol. (2006)
- In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Michel, M.C., Okutsu, H., Noguchi, Y., Suzuki, M., Ohtake, A., Yuyama, H., Yanai-Inamura, H., Ukai, M., Watanabe, M., Someya, A., Sasamata, M. Naunyn Schmiedebergs Arch. Pharmacol. (2006)
- An anthology from Naunyn-Schmiedeberg's Archives of Pharmacology. Michel, M.C. Naunyn Schmiedebergs Arch. Pharmacol. (2006)
- Transient receptor potential (TRP) channels as drug targets. Michel, M.C. Naunyn Schmiedebergs Arch. Pharmacol. (2006)
- Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?. Michel, M.C., Hegde, S.S. Naunyn Schmiedebergs Arch. Pharmacol. (2006)
- Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Michel, M.C., de la Rosette, J.J., Piro, M., Schneider, T. Eur. Urol. (2005)
- Role of muscarinic receptor antagonists in urgency and nocturia. Michel, M.C., de la Rosette, J.J. BJU Int. (2005)
- Duloxetine in the treatment of stress urinary incontinence. Michel, M.C., Oelke, M. Women's. Health. (london,. England) (2005)
- Efficacy and safety of tamsulosin in the treatment of urological diseases. Michel, M.C., de la Rosette, J.J. Expert. Opin. Pharmacother (2004)
- Safety of telmisartan in patients with arterial hypertension : an open-label observational study. Michel, M.C., Bohner, H., Köster, J., Schäfers, R., Heemann, U. Drug. Saf (2004)
- Role of serotonin and noradrenaline in stress urinary incontinence. Michel, M.C., Peters, S.L. BJU Int. (2004)
- Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder?. Michel, M.C., de la Rosette, J.J., Piro, M., Goepel, M. J. Urol. (2004)
- Association of hypertension with symptoms of benign prostatic hyperplasia. Michel, M.C., Heemann, U., Schumacher, H., Mehlburger, L., Goepel, M. J. Urol. (2004)
